Miracle Mile Advisors, LLC Astrazeneca PLC Transaction History

Miracle Mile Advisors, LLC

$4.72 Billion
Q4 2024

A detailed history of Miracle Mile Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Miracle Mile Advisors, LLC holds 39,986 shares of AZN stock, worth $2.98 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

39,986

Previous 7,327 445.73%

Holding current value

$2.98 Million

Previous $570,000 359.47%

% of portfolio

0.06%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	BUY	$63.2 - $79.58 $2.06 Million - $2.6 Million	32,659 Added 445.73%	39,986 $2.62 Million
Q3 2024 Oct 07, 2024	SELL	$76.67 - $87.62 $76,516 - $87,444	-998 Reduced 11.99%	7,327 $570,000
Q2 2024 Jul 18, 2024	BUY	$66.81 - $80.83 $47,501 - $57,470	711 Added 9.34%	8,325 $649,000
Q1 2024 Apr 18, 2024	BUY	$61.03 - $69.57 $34,909 - $39,794	572 Added 8.12%	7,614 $515,000
Q4 2023 Jan 22, 2024	SELL	$61.89 - $69.28 $2.04 Million - $2.28 Million	-32,978 Reduced 82.4%	7,042 $474,000
Q3 2023 Oct 25, 2023	SELL	$64.85 - $71.7 $32,424 - $35,850	-500 Reduced 1.23%	40,020 $2.71 Million
Q2 2023 Jul 13, 2023	BUY	$69.91 - $75.81 $41,946 - $45,486	600 Added 1.5%	40,520 $2.9 Million
Q4 2022 Jan 20, 2023	BUY	$54.21 - $70.44 $74,430 - $96,714	1,373 Added 3.56%	39,920 $0
Q3 2022 Oct 24, 2022	SELL	$53.02 - $135.75 $16,860 - $43,168	-318 Reduced 0.82%	38,547 $2.11 Million
Q2 2022 Jul 15, 2022	SELL	$59.26 - $71.14 $829 - $995	-14 Reduced 0.04%	38,865 $2.57 Million
Q1 2022 Apr 25, 2022	BUY	$55.72 - $67.12 $1.95 Million - $2.35 Million	35,003 Added 903.07%	38,879 $2.58 Million
Q4 2021 Jan 18, 2022	BUY	$54.02 - $63.83 $209,381 - $247,405	3,876 New	3,876 $226,000

Others Institutions Holding AZN

# of Institutions

1,343

Shares Held

477M

Call Options Held

5.29M

Put Options Held

3.79M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $231B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Miracle Mile Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miracle Mile Advisors, LLC with notifications on news.

Account

Miracle Mile Advisors, LLC Astrazeneca PLC Transaction History